In addition, TIPE2 inhibited invasiveness and tumor development via reducing MMP9 expression by targeting Rac1 in hepatocellular carcinoma (HCC) and gastrointestinal stromal tumor (11, 12). This evidence concerns the gene MMP9 and hepatocellular carcinoma.